Changes in neostriatal DA metabolism after carbachol or atropine microinjections into the substantia nigra.
D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001285:Atropine / Q000008:administration & dosage* / Q000494:pharmacology; D002217:Carbachol / Q000008:administration & dosage* / Q000494:pharmacology; D002421:Caudate Nucleus / Q000378:metabolism; D002852:Chromatography, Ion Exchange; D003342:Corpus Striatum / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000302:isolation & purification / Q000378:metabolism; D004298:Dopamine / Q000302:isolation & purification / Q000378:metabolism*; D006834:Hydrazines / Q000494:pharmacology; D007275:Injections, Intravenous; D008297:Male; D008722:Methods; D008845:Microinjections; D051381:Rats; D013378:Substantia Nigra / Q000187:drug effects*; D013997:Time Factors; D014316:Tritium; D014443:Tyrosine / Q000008:administration & dosage / Q000302:isolation & purification / Q000378:metabolism
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D006834:Hydrazines; D014316:Tritium; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D001285:Atropine; D002217:Carbachol; D004298:Dopamine